Evidence map›Paper›PMID 11909956›Full record

ArticleMolecular and cellular biology2002

Inducer-specific enhanceosome formation controls tumor necrosis factor alpha gene expression in T lymphocytes.

Alla V Tsytsykova, Anne E Goldfeld

Open access · bronzeAbstract read
In one paragraph

Article in Molecular and cellular biology, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 1 synthesis or guideline pooled it, 68 citations in OpenAlex.

  1. Pooled it
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Transcriptional control of the TNF gene.Current directions in autoimmunity · 2010
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Alla V TsytsykovaThe Center for Blood Research and Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115, USA.
Anne E Goldfeld
Dana-Farber/Boston Children's Cancer and Blood Disorders Center · US

Funding

IMMUNOLOGICAL ACTIVATION OF TNF ALPHA GENE EXPRESSIONR01GM056492 · NIGMS · IMMUNE DISEASE INSTITUTE, INC. · PI GOLDFELD, ANNE · 1999 to 2003
$1.1M
NIGMS NIH HHS GM-56492NIGMS NIH HHS R01 GM056492
6 · The paper itself

Abstract

We present evidence that the inducer-specific regulation of the human tumor necrosis factor alpha (TNF-alpha) gene in T cells involves the assembly of distinct higher-order transcription enhancer complexes (enhanceosomes), which is dependent upon inducer-specific helical phasing relationships between transcription factor binding sites. While ATF-2, c-Jun, and the coactivator proteins CBP/p300 play a central role in TNF-alpha gene activation stimulated by virus infection or intracellular calcium flux, different sets of activators including NFATp, Sp1, and Ets/Elk are recruited to a shared set of transcription factor binding sites depending upon the particular stimulus. Thus, these studies demonstrate that the inducer-specific assembly of unique enhanceosomes is a general mechanism by which a single gene is controlled in response to different extracellular stimuli.

Indexed as

Nuclear ProteinsBase SequenceBinding SitesCell LineDNADNA-Binding ProteinsEnhancer Elements, GeneticGene Expression RegulationHumansModels, BiologicalMolecular Sequence DataNFATC Transcription FactorsPromoter Regions, GeneticProto-Oncogene ProteinsProto-Oncogene Proteins c-etsSp1 Transcription FactorDNADNA-Binding ProteinsNFATC Transcription FactorsNuclear ProteinsProto-Oncogene ProteinsProto-Oncogene Proteins c-etsSp1 Transcription FactorTranscription FactorsTumor Necrosis Factor-alpha

Identifiers

PMID11909956
PMCPMC133734
OpenAlexW2069405394

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.